Pediatric Intensive Care Unit admission criteria for haemato-oncological patients: a basis for clinical guidelines implementation
- PMID: 21772950
- PMCID: PMC3133495
- DOI: 10.4081/pr.2011.e13
Pediatric Intensive Care Unit admission criteria for haemato-oncological patients: a basis for clinical guidelines implementation
Abstract
Recent advances in supportive care and progress in the development and use of chemotherapy have considerably improved the prognosis of many children with malignancy, thus the need for intensive care admission and management is increasing, reaching about 40% of patients throughout the disease course. Cancer remains a major death cause in children, though outcomes have considerably improved over the past decades. Prediction of outcome for children with cancer in Pediatric Intensive Care Unit (PICU) obviously requires clinical guidelines, and these are not well defined, as well as admission criteria. Major determinants of negative outcomes remain severe sepsis/septic shock association and respiratory failure, deserving specific approach in children with cancer, particularly those receiving a bone marrow transplantation. A nationwide consensus should be achieved among pediatric intensivists and oncologists regarding the threshold clinical conditions requiring Intensive Care Unit (ICU) admission as well as specific critical care protocols. As demonstrated for the critically ill non-oncologic child, it appears unreasonable that pediatric patients with malignancy can be admitted to an adult Intensive Care Unit ICU. On a national basis a pool of refecence institutions should be identified and early referral to an oncologic PICU is warranted.
Keywords: Pediatric Intensive Care Unit admission criteria; children; critically ill.; intensive care; malignancy.
References
-
- Waskerwitz MJ, Ruccione K. An overview of cancer in children in the 1980s. Nurs Clin North Am. 1985;20:5–29. - PubMed
-
- Bleyer WA. Epidemiologic impact of children with brain tumors. Childs Nerv Syst. 1999;15:758–763. - PubMed
-
- Bleyer WA. The US Pediatric cancer clinical trials programmes: International implications and the way forward. Eur J Cancer. 1997;33:1439–47. - PubMed
-
- Friedmann AM, Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist. 2000;5:321–8. - PubMed
-
- Creutzig U, Zimmermann M, Ritter J, et al. Definition of a standard-risk group in children with AML. Br J Haematol. 1999;104:630–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous